Journal of Lipid Research, Vol 31, 1613-1625, Copyright © 1990 by Lipid Research, Inc.

ARTICLES

Transport of lipid and apolipoproteins A-I and A-IV in intestinal lymph of the rat

H Hayashi, DF Nutting, K Fujimoto, JA Cardelli, D Black and P Tso
Department of Physiology, Louisiana State University Medical Center, Shreveport 71130.

Intestinal lipid absorption is associated with marked increases in the synthesis and secretion of apolipoprotein A-IV (apoA-IV) by the small intestine. Whether the increased intestinal apoA-IV synthesis and secretion results from increased fat uptake, increased cellular triglyceride (TG) content, or increased secretion of TG-rich lipoproteins by the enterocytes is unknown. Previous work from this laboratory has shown that a hydrophobic surfactant, Pluronic L-81 (L- 81), is a potent inhibitor of intestinal formation of chylomicrons (CM), without reducing fat uptake or re-synthesis to TG. Furthermore, this inhibition can be reversed quickly by the cessation of L-81 infusion. Thus L-81 offers a unique opportunity to study the relationship between lymphatic TG, apoA-I and A-IV secretion. In this study, we studied the lymphatic transport of TG, apoA-I, and apoA-IV during both the inhibitory phase (L-81 infused together with lipid) and the subsequent unblocking phase (saline infusion). Two groups of lymph fistula rats were used, the control and the experimental rats. In the experimental rats, a phosphate-buffered taurocholate-stabilized emulsion containing 40 mumol [3H]triolein, 7.8 mumol of phosphatidylcholine, and 1 mg L-81 per 3 ml was infused at 3 ml/h for 8 h. This was then replaced by glucose-saline infusion for an additional 12 h. The control rats received the same lipid emulsion as the experimental rats, but without L-81 added, for 8 h. Lymph lipid was determined both by radioactivity and by glyceride-glycerol determination, and the apoA-I and apoA-IV concentrations were determined by rocket electroimmunophoresis assay. L-81 inhibited the rise in lymphatic lipid and apoA-IV output in the experimental rats after the beginning of lipid + L-81 infusion. Upon cessation of L-81 infusion, the mucosal lipid accumulated as a result of L-81 treatment was rapidly cleared into lymph as CM. This was associated with a marked increase in apoA-IV output; the maximal output was about 3 times that of the fasting level. There was a time lag of 4-5 h between the peak lymph lipid output and the peak lymph apoA-IV output during the unblocking phase in the experimental rats. There was also a comparable time lag between the maximal lipid and apoA-IV outputs in the control animals. Incorporation studies using [3H]leucine showed that apoA-IV synthesis was not stimulated during lipid + L-81 infusion, perhaps explaining the lack of increase in lymphatic A-IV secretion.(ABSTRACT TRUNCATED AT 400 WORDS)
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				W. J. Lu, Q. Yang, W. Sun, S. C. Woods, D. D'Alessio, and P. Tso Using the lymph fistula rat model to study the potentiation of GIP secretion by the ingestion of fat and glucose Am J Physiol Gastrointest Liver Physiol, May 1, 2008; 294(5): G1130 - G1138. [Abstract] [Full Text] [PDF]

				W. J. Lu, Q. Yang, W. Sun, S. C. Woods, D. D'Alessio, and P. Tso The regulation of the lymphatic secretion of glucagon-like peptide-1 (GLP-1) by intestinal absorption of fat and carbohydrate Am J Physiol Gastrointest Liver Physiol, November 1, 2007; 293(5): G963 - G971. [Abstract] [Full Text] [PDF]

				C. M. Lo, D. M. Zhang, K. Pearson, L. Ma, W. Sun, R. R. Sakai, W. S. Davidson, M. Liu, H. E. Raybould, S. C. Woods, et al. Interaction of apolipoprotein AIV with cholecystokinin on the control of food intake Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2007; 293(4): R1490 - R1494. [Abstract] [Full Text] [PDF]

				C.-M. Lo, L. Ma, D. M. Zhang, R. Lee, A. Qin, M. Liu, S. C Woods, R. R. Sakai, H. E. Raybould, and P. Tso Mechanism of the induction of brain c-Fos-positive neurons by lipid absorption Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2007; 292(1): R268 - R273. [Abstract] [Full Text] [PDF]

				H. L. Spaulding, F. Saijo, R. H. Turnage, J. S. Alexander, T. Y. Aw, and T. J. Kalogeris Apolipoprotein A-IV attenuates oxidant-induced apoptosis in mitotic competent, undifferentiated cells by modulating intracellular glutathione redox balance Am J Physiol Cell Physiol, January 1, 2006; 290(1): C95 - C103. [Abstract] [Full Text] [PDF]

				V. Carriere, R. Vidal, K. Lazou, M. Lacasa, F. Delers, A. Ribeiro, M. Rousset, J. Chambaz, and J. M. Lacorte HNF-4-dependent Induction of Apolipoprotein A-IV Gene Transcription by an Apical Supply of Lipid Micelles in Intestinal Cells J. Biol. Chem., February 18, 2005; 280(7): 5406 - 5413. [Abstract] [Full Text] [PDF]

				L. Shen, L.-y. Ma, X.-f. Qin, R. Jandacek, R. Sakai, and M. Liu Diurnal changes in intestinal apolipoprotein A-IV and its relation to food intake and corticosterone in rats Am J Physiol Gastrointest Liver Physiol, January 1, 2005; 288(1): G48 - G53. [Abstract] [Full Text] [PDF]

				J. W. Gallagher, R. B. Weinberg, and G. S. Shelness apoA-IV tagged with the ER retention signal KDEL perturbs the intracellular trafficking and secretion of apoB J. Lipid Res., October 1, 2004; 45(10): 1826 - 1834. [Abstract] [Full Text] [PDF]

				M. Liu, L. Shen, Y. Liu, S. C. Woods, R. J. Seeley, D. D'Alessio, and P. Tso Obesity induced by a high-fat diet downregulates apolipoprotein A-IV gene expression in rat hypothalamus Am J Physiol Endocrinol Metab, August 1, 2004; 287(2): E366 - E370. [Abstract] [Full Text] [PDF]

				M. Liu, L. Shen, Y. Liu, D. Tajima, R. Sakai, S. C. Woods, and P. Tso Diurnal Rhythm of Apolipoprotein A-IV in Rat Hypothalamus and Its Relation to Food Intake and Corticosterone Endocrinology, July 1, 2004; 145(7): 3232 - 3238. [Abstract] [Full Text] [PDF]

				P. Tso, W. Sun, and M. Liu Gastrointestinal Satiety Signals IV. Apolipoprotein A-IV Am J Physiol Gastrointest Liver Physiol, June 1, 2004; 286(6): G885 - G890. [Abstract] [Full Text] [PDF]

				M. Liu, T. Doi, and P. Tso Regulation of Intestinal and Hypothalamic Apolipoprotein A-IV Experimental Biology and Medicine, November 1, 2003; 228(10): 1181 - 1189. [Abstract] [Full Text] [PDF]

				H E Raybould Visceral perception: sensory transduction in visceral afferents and nutrients Gut, July 1, 2002; 51(90001): i11 - 14. [Abstract] [Full Text]

				R. B. Weinberg, R. A. Anderson, V. R. Cook, F. Emmanuel, P. Denefle, A. R. Tall, and A. Steinmetz Interfacial Exclusion Pressure Determines the Ability of Apolipoprotein A-IV Truncation Mutants to Activate Cholesterol Ester Transfer Protein J. Biol. Chem., June 7, 2002; 277(24): 21549 - 21553. [Abstract] [Full Text] [PDF]

				H. Hayashi, Y. Sato, S. Kanai, M. Ichikawa, A. Funakoshi, and K. Miyasaka Increased lymphatic lipid transport in genetically diabetic obese rats Am J Physiol Gastrointest Liver Physiol, January 1, 2002; 282(1): G69 - G76. [Abstract] [Full Text] [PDF]

				J. Glatzle, T. J. Kalogeris, T. T. Zittel, S. Guerrini, P. Tso, and H. E. Raybould Chylomicron components mediate intestinal lipid-induced inhibition of gastric motor function Am J Physiol Gastrointest Liver Physiol, January 1, 2002; 282(1): G86 - G91. [Abstract] [Full Text] [PDF]

				Z. Sun, F. K Welty, G. G Dolnikowski, A. H Lichtenstein, and E. J Schaefer Effects of a National Cholesterol Education Program Step II Diet on apolipoprotein A-IV metabolism within triacylglycerol-rich lipoproteins and plasma Am. J. Clinical Nutrition, September 1, 2001; 74(3): 308 - 314. [Abstract] [Full Text]

				T. Doi, M. Liu, R. J. Seeley, S. C. Woods, and P. Tso Effect of leptin on intestinal apolipoprotein AIV in response to lipid feeding Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2001; 281(3): R753 - R759. [Abstract] [Full Text] [PDF]

				Y. Umeda, Y. Kako, K. Mizutani, Y. Iikura, M. Kawamura, M. Seishima, and H. Hayashi Inhibitory action of gemfibrozil on cholesterol absorption in rat intestine J. Lipid Res., August 1, 2001; 42(8): 1214 - 1219. [Abstract] [Full Text] [PDF]

				M. Liu, T. Doi, L. Shen, S. C. Woods, R. J. Seeley, S. Zheng, A. Jackman, and P. Tso Intestinal satiety protein apolipoprotein AIV is synthesized and regulated in rat hypothalamus Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2001; 280(5): R1382 - R1387. [Abstract] [Full Text] [PDF]

				T. J. Kalogeris and R. G. Painter Adaptation of intestinal production of apolipoprotein A-IV during chronic feeding of lipid Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2001; 280(4): R1155 - R1161. [Abstract] [Full Text] [PDF]

				K. J. Hockey, R. A. Anderson, V. R. Cook, R. R. Hantgan, and R. B. Weinberg Effect of the apolipoprotein A-IV Q360H polymorphism on postprandial plasma triglyceride clearance J. Lipid Res., February 1, 2001; 42(2): 211 - 217. [Abstract] [Full Text]

				R. B. Weinberg, B. W. Geissinger, K. Kasala, K. J. Hockey, J. G. Terry, L. Easter, and J. R. Crouse Effect of apolipoprotein A-IV genotype and dietary fat on cholesterol absorption in humans J. Lipid Res., December 1, 2000; 41(12): 2035 - 2041. [Abstract] [Full Text]

				R. B. Weinberg, R. A. Anderson, V. R. Cook, F. Emmanuel, P. Denefle, M. Hermann, and A. Steinmetz Structure and interfacial properties of chicken apolipoprotein A-IV J. Lipid Res., September 1, 2000; 41(9): 1410 - 1418. [Abstract] [Full Text]

				R. B. Weinberg, V. R. Cook, J. A. DeLozier, and G. S. Shelness Dynamic interfacial properties of human apolipoproteins A-IV and B-17 at the air/water and oil/water interface J. Lipid Res., September 1, 2000; 41(9): 1419 - 1427. [Abstract] [Full Text]

				N. Fournier, V. Atger, J.-L. Paul, M. Sturm, N. Duverger, G. H. Rothblat, and N. Moatti Human ApoA-IV Overexpression in Transgenic Mice Induces cAMP-Stimulated Cholesterol Efflux From J774 Macrophages to Whole Serum Arterioscler. Thromb. Vasc. Biol., May 1, 2000; 20(5): 1283 - 1292. [Abstract] [Full Text] [PDF]

				K. Sonoyama, K. Tajima, R. Fujiwara, and T. Kasai Intravenous Infusion of Hexamethonium and Atropine But Not Propranolol Diminishes Apolipoprotein A-IV Gene Expression in Rat Ileum J. Nutr., March 1, 2000; 130(3): 637 - 641. [Abstract] [Full Text]

				T. J. Kalogeris, R. G. Painter, and V. R. Holden Ileal Lipid Infusion Stimulates Jejunal Synthesis of Apolipoprotein A-IV Without Affecting mRNA Levels Experimental Biology and Medicine, February 1, 2000; 223(2): 198 - 202. [Abstract] [Full Text]

				H. E. Raybould Nutrient Tasting and Signaling Mechanisms in the Gut. I. Sensing of lipid by the intestinal mucosa Am J Physiol Gastrointest Liver Physiol, October 1, 1999; 277(4): G751 - G755. [Abstract] [Full Text] [PDF]

				P. Tso, M. Liu, and T. J. Kalogeris The Role of Apolipoprotein A-IV in Food Intake Regulation J. Nutr., August 1, 1999; 129(8): 1503 - 1506. [Abstract] [Full Text]

				R. M. Fisher, H. Burke, V. Nicaud, C. Ehnholm, and S. E. Humphries Effect of variation in the apo A-IV gene on body mass index and fasting and postprandial lipids in the European Atherosclerosis Research Study II J. Lipid Res., February 1, 1999; 40(2): 287 - 294. [Abstract] [Full Text]

				T. J. Kalogeris, X. Qin, W. Y. Chey, and P. Tso PYY stimulates synthesis and secretion of intestinal apolipoprotein AIV without affecting mRNA expression Am J Physiol Gastrointest Liver Physiol, October 1, 1998; 275(4): G668 - G674. [Abstract] [Full Text] [PDF]

				X. Qin, D. K. Swertfeger, S. Zheng, D. Y. Hui, and P. Tso Apolipoprotein AIV: a potent endogenous inhibitor of lipid oxidation Am J Physiol Heart Circ Physiol, May 1, 1998; 274(5): H1836 - H1840. [Abstract] [Full Text] [PDF]

				T. J. Kalogeris, M.-D. Rodriguez, and P. Tso Control of Synthesis and Secretion of Intestinal Apolipoprotein A-IV by Lipid J. Nutr., March 1, 1997; 127(3): 537 - 537. [Abstract] [Full Text]